EL-ANCA: ANTI-MPO, ANTI-PR3, ANTI-MPO AND ANTI-PR3

Test System, Antineutrophil Cytoplasmic Antibodies (anca)

THERATEST LABORATORIES, INC.

The following data is part of a premarket notification filed by Theratest Laboratories, Inc. with the FDA for El-anca: Anti-mpo, Anti-pr3, Anti-mpo And Anti-pr3.

Pre-market Notification Details

Device IDK061376
510k NumberK061376
Device Name:EL-ANCA: ANTI-MPO, ANTI-PR3, ANTI-MPO AND ANTI-PR3
ClassificationTest System, Antineutrophil Cytoplasmic Antibodies (anca)
Applicant THERATEST LABORATORIES, INC. 1111 N. MAIN ST. Lombard,  IL  60148
ContactMarius Teodorescu, Md, Ph.d.
CorrespondentMarius Teodorescu, Md, Ph.d.
THERATEST LABORATORIES, INC. 1111 N. MAIN ST. Lombard,  IL  60148
Product CodeMOB  
CFR Regulation Number866.5660 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2006-05-17
Decision Date2006-07-20

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00854473003248 K061376 000
00854473003231 K061376 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.